Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advances in Radiation Therapy for Primary Bone Malignancies.

Technology in cancer research & treatment·2026
Same author

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

JAMA oncology·2026
Same author

Tumor Genomics, Metastatic Patterns, and Prognosis in Leiomyosarcoma: A Single-Center Retrospective Cohort Study.

Cancers·2025
Same author

DNA Damage Repair Pathway Alterations and Immune Landscape Differences in Pediatric/Adolescent, Young Adult (AYA) and Adult Sarcomas.

Cancers·2025
Same author

Drug Sensitivity Testing in Osteosarcoma: A Case Report.

Current oncology (Toronto, Ont.)·2025

Related Experiment Video

Updated: Jul 14, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Sarcoma molecular testing: diagnosis and prognosis.

Alexander J F Lazar1, Jonathan C Trent, Dina Lev

  • 1Department of Pathology and Sarcoma Research Center, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA. alazar@mdanderson.org

Current Oncology Reports
|June 26, 2007
PubMed
Summary

Soft tissue sarcoma molecular testing aids diagnosis via fusion transcripts. Prognostic testing shows promise but needs more research, while KIT mutation analysis guides gastrointestinal stromal tumor therapy.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Experiment Videos

Last Updated: Jul 14, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Genetics

Background:

  • Soft tissue sarcomas are rare mesenchymal tumors with complex molecular profiles.
  • Accurate diagnosis and prognosis are crucial for effective patient management.
  • Current molecular testing primarily focuses on diagnostic markers.

Purpose of the Study:

  • To review current methodologies in soft tissue sarcoma molecular testing.
  • To highlight the diagnostic utility of chromosomal translocations and fusion transcripts.
  • To discuss the potential of molecular prognostic testing and KIT mutation analysis.

Main Methods:

  • Review of diagnostic and prognostic molecular testing techniques in soft tissue sarcomas.
  • Analysis of chromosomal translocations and resulting fusion transcripts for diagnosis.
  • Examination of activating KIT mutations for therapeutic guidance in gastrointestinal stromal tumors.

Main Results:

  • Chromosomal translocations and fusion transcripts are key diagnostic tools in soft tissue sarcoma.
  • Molecular prognostic testing shows potential but requires further validation.
  • KIT mutation analysis is an established method for guiding therapy in gastrointestinal stromal tumors.

Conclusions:

  • Molecular testing, particularly for diagnostic markers like fusion transcripts, is advancing soft tissue sarcoma diagnosis.
  • Further research is needed to confirm the clinical utility of molecular prognostic markers.
  • Targeted mutation analysis, such as for KIT, plays a vital role in current patient management for specific sarcoma subtypes.